These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7440706)

  • 1. Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.
    Lightman SL; Langdon N; Forsling ML
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1447-9. PubMed ID: 7440706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vasopressin release in man by an opiate peptide.
    Grossman A; Besser GM; Milles JJ; Baylis PH
    Lancet; 1980 Nov; 2(8204):1108-10. PubMed ID: 6107725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a [Met]-enkephalin analogue ( [D-Ala2,N-Me-Phe4,Met-(O)5-ol]-enkephalin) on canine pituitary function.
    Meij BP; Rijnberk A; Mol JA
    J Endocrinol; 1990 Nov; 127(2):265-71. PubMed ID: 2174454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof for histaminergic but not for adrenergic involvement in the growth hormone-releasing effect of an enkephalin analog in the dog.
    Casanueva F; Betti R; Cocchi D; Chieli T; Mantegazza P; Müller EE
    Endocrinology; 1981 Jan; 108(1):157-63. PubMed ID: 7460816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effect of the enkephalin analogue FK-33824 on vasopressin secretion in conscious sheep.
    Wang XM; Tresham JJ; Congiu M; Scoggins BA; Coghlan JP
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):369-73. PubMed ID: 2929239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in man.
    Bouloux PM; Grossman A; Lytras N; Besser GM
    Clin Endocrinol (Oxf); 1985 Jan; 22(1):49-56. PubMed ID: 3884188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioids and baroreflex control in humans.
    Rubin PC; McLean K; Reid JL
    Hypertension; 1983; 5(4):535-8. PubMed ID: 6862578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Met-enkephalin analogue and naloxone infusion on anterior pituitary hormone secretion in acromegaly.
    Delitala G; Giusti M; Borsi L; Devilla L; Mazzochi G; Lotti G; Giordano G
    Horm Res; 1981; 15(2):88-98. PubMed ID: 6276286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an enkephalin analogue (DAMME) on insulin release from cultured rat islets of Langerhans.
    Pierluissi R; Pierluissi J; Ashcroft SJ
    Diabetologia; 1981 Jun; 20(6):642-6. PubMed ID: 6790327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine is not involved in the opioid control of luteinizing hormone secretion in man.
    Foresta C; Indino M; Federspil G; Scandellari C
    Fertil Steril; 1985 Oct; 44(4):504-7. PubMed ID: 4054321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and oxytocin responses to hypertonic saline infusion: effect of the opioid antagonist naloxone.
    Seckl JR; Johnson MR; Lightman SL
    Clin Endocrinol (Oxf); 1989 May; 30(5):513-8. PubMed ID: 2605788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
    Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
    Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies off the opiate control of prolactin, GH and TSH.
    Grossman A; Stubbs WA; Gaillard RC; Delitala G; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):381-6. PubMed ID: 7021012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic clearance rate in sheep of a met-enkephalin analogue estimated by radioimmunoassay.
    Bolton JE; Livesey JH; Donald RA
    J Endocrinol; 1982 Jun; 93(3):427-33. PubMed ID: 6806424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A met-enkephalin analog inhibits adrenocorticotropin secretion by cultured pituitary cells from a patient with Nelson's syndrome.
    Lamberts SW; Oosterom R; Verleun T; Bons EG; Uitterlinden P
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1084-6. PubMed ID: 6270182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.
    Grossman A; Moult PJ; Gaillard RC; Delitala G; Toff WD; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):41-7. PubMed ID: 6784982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone.
    Delitala G; Tomasi PA; Palermo M; Ross RJ; Grossman A; Besser GM
    J Clin Endocrinol Metab; 1989 Aug; 69(2):356-8. PubMed ID: 2546963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorphins: "opiates for the masses".
    Grossman A
    Med Sci Sports Exerc; 1985 Feb; 17(1):101-5. PubMed ID: 2984513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a met-enkephalin analogue and naloxone infusion on gonadotrophin secretion in man.
    Delitala G; Giusti M; Devilla L; Mazzocchi G; Lotti G; Giordano G
    Acta Eur Fertil; 1981 Sep; 12(3):287-8. PubMed ID: 6803502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.